Consequently, based on the available evidence, it may be concluded that, compared to the control group, the HPV vaccine appears not to increase the frequency of serious adverse effects 3, although it does increase minor local and systemic adverse effects 4.
De esta forma, y a partir de la evidencia disponible, podemos concluir que comparada frente al grupo control, la administración de la vacuna para el VPH parece no incrementar la frecuencia de efectos adversos serios 3 pero sí la de efectos adversos menores locales y sistémicos 4.